Present Trends in Newborn Screening, Genetic Counseling, and Emerging Drug Therapies in the Effective Treatment of Alpha (α)-Thalassemia in the MENA Region
January 21, 2022
The occurrence of thalassemia is an issue of major concern in the health sector of certain countries, including the Middle East and North Africa (MENA region), Southeast Asia, Central Asia, and the Indian subcontinent. According to DelveInsight’s analysis based secondary sources, countries in the MENA region, particularly the Gulf Cooperation […]

Current Treatment and Development for Spinal Muscular Atrophy (SMA) in MENA region
January 3, 2022
According to the Centre for Arab Genomic Studies, the SMA prevalence in Gulf Cooperation Council (GCC) populations is thought to be at least 50 times higher than in the US, with more than 50 cases per 100,000 live births, compared to only 1.2 in the US. Additionally, various studies conducted […]

Can Headways in Newborn Screening and Emerging Therapies Revamp the Treatment and Diagnosis of Duchene Muscular Dystrophy (DMD) in the MENA Region?
December 16, 2021
Duchenne muscular dystrophy (DMD) is a rare and severe X-linked neuromuscular childhood disorder – predominantly present in males – caused by an absence of dystrophin protein due to mutations of the DMD gene located on the short arm of the X chromosome. Symptoms are usually observed between the ages of 1–6 […]

Overlaying Retinitis Pigmentosa (RP) Management in the MENA Region
November 22, 2021
An analysis of the current scenario and future perspective of Retinitis Pigmentosa epidemiology and management specific to the MENA region! Retinitis Pigmentosa is inherited retinal dystrophy caused by the gradual atrophy of the photoreceptor cells in the retina and characterized by progressive degeneration of the retina and progressive vision loss […]

Cancer diagnosis in the MENA region: Headway toward a better future
November 18, 2021
Cancer is an increasing problem not just in the Middle East and North Africa (MENA) region but also globally, securing a significant place as the leading cause of death. It is a major public health problem that affects every country in the MENA region regardless of economic and social situation. […]

Capping Atopic Dermatitis in the MENA Region
November 10, 2021
A review of the current state of AD management in the MENA region Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by intense itching and recurrent eczematous lesions. According to various secondary sources, the prevalence of AD in regions of the Middle East and North Africa (MENA) has […]

Orphan drugs in the MENA region: Interpreting the market access through the lens of current regulations and market dynamics
November 2, 2021
Around 2.8 million people suffer from a rare disease in the MENA region, afflicted with more than 900 rare diseases, including Gaucher disease, Fabry disease, thalassemia, sickle cell disease, etc. The prevalence rate of rare diseases in the MENA region is high due to consanguineous marriages – a significant contributory […]

MedTech Industry in GCC post-Covid-19
October 17, 2021
COVID-19 is a contagious disease that tends to affect the respiratory system in humans caused by the SARS-COV-2 virus. In December 2019, the virus was first encountered in Wuhan, China and the infection quickly spread across China, and then other countries. On March 11, 2020, COVID-19 was declared a pandemic […]

Symbiosis Between Pharma Industry and Healthcare Professionals
October 7, 2021
National Geographic in one of its articles says that symbiosis is the art of living together. (1) Symbiotic relationships are an important component of life in the ecosystem of jungles and the oceans. Plants or animals of different species are dependent on one another for survival. There should be a […]

What is Fuelling the Healthcare Market Space in the MENA?
September 29, 2021
Healthcare Industry in the MENA Region Healthcare comes out as one of the most promising industries in the MENA region, owing to strong demand and supply considerations. The MENA healthcare sector’s potential for rapid development and relative stability has piqued the interest of several private equity (PE) firms. Therefore, healthcare […]

Telehealth: Is it the Future of Healthcare in the MENA Region?
September 19, 2021
Various advancements in the healthcare sector have been made due to a compelling blend of technology and the health profession. In this current era of communication and information technology, Telehealth is not only being used for long-distance consultations but has also led to the emergence of various health-related educational resources […]

Pompe Disease – Rare but still Matters
August 18, 2021
Pompe Diseases are usually characterized by a deficiency of an enzyme called acid alfa glucosidase (GAA). The enzyme helps by breaking down complex sugars in the body which, when in deficiency causes Pompe disease. The disease is a rare disorder with a current worldwide prevalence of 1 in 5,000 to […]

The Biosimilars scenario in the MENA Region
August 18, 2021
Biosimilars, a cost-effective alternative to expensive biologics, have emerged to become a viable solution to the patient access barrier which impacted earlier in case of biologics. Biosimilars are increasingly becoming popular for treating a wide range of life-threatening diseases and represent a rapidly expanding segment of pharmaceutical industry. As the […]

A rare condition with a slight Middle Eastern link – Acid sphingomyelinase deficiency (ASMD)
August 18, 2021
Orphan genetic diseases afflict a minimal number of people. Relatively rare, they still do affect millions of people, collectively contributing to Global disease burden. Studies conducted estimates that there are as many as 7,000 diseases that are designated as rare, and one out of 15 persons worldwide are estimated to […]

Healthcare Burden and subsequent advances in the Healthcare Sector of UAE
August 18, 2021
The United Arab Emirates is ranked among one of the most developed countries in the world. According to a survey by the World Bank, the GDP of the UAE reached all-time high to USD 414.18 Billion last year, an increase of around USD 399.458 Billion from USD 14.721 Billion in […]
